Polyphor AG (POLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Polyphor AG (Polyphor) is a clinical stage biopharmaceutical company that discovers and develops antibiotics and other specialty pharma products for severe or life-threatening diseases. The company offers hematopoietic stem cells for multiple myeloma patients, Pseudomonas infections and protease inhibitors for chronic obstructive pulmonary disease, alpha-1-antitrypsin deficiency, cystic fibrosis and lung diseases, among others. It develops various technology platforms which include MacroFinder and PEMfinder that are used to discover the potent and selective modulators of protein-protein interactions. It also develops proprietary macrocycle technology platform for pharma companies. Polyphor is headquartered in Allschwil, Switzerland.

Polyphor AG (POLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Polyphor AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Polyphor AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Polyphor AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Polyphor AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Polyphor AG, Medical Devices Deals, 2012 to YTD 2018 9
Polyphor AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Polyphor AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Polyphor Enters into Licensing Agreement with PARI Pharma 11
Polyphor Enters into Research Agreement with Taisho Pharma 12
Licensing Agreements 13
Santhera Pharma Enters into Licensing Agreement with Polyphor 13
Polyphor Extends Licensing Agreement with Boehringer Ingelheim 14
Gilead Sciences Enters Into Licensing Agreement With Polyphor 15
Equity Offering 16
Polyphor Raises USD167.4 Million in IPO of Shares 16
Polyphor Raises USD10 Million in Private Financing 17
Polyphor AG - Key Competitors 18
Polyphor AG - Key Employees 19
Polyphor AG - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
May 24, 2017: Kalina Scott appointed new CFO of Polyphor 21
Government and Public Interest 22
Jan 23, 2018: Polyphor: Global No. 2 in the 2018 Antimicrobial Resistance Benchmark published by the Access to Medicine Foundation 22
Product News 23
07/18/2017: Polyphor achieves ahead of schedule first milestone from Wellcome Trust for the development of novel antibiotics against Gram-negative multidrug - resistant pathogens 23
02/09/2017: Polyphor Receives CHF 2.3 Million Award from Wellcome Trust to Accelerate the Development of a Novel Antibiotic Drug Class 24
Other Significant Developments 25
Apr 13, 2018: Polyphor successfully completes Wellcome Trust collaboration for development of novel antibiotics against multi-drug resistant Gram-negative pathogens 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List Of Tables


Polyphor AG, Pharmaceuticals & Healthcare, Key Facts 2
Polyphor AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Polyphor AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Polyphor AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Polyphor AG, Deals By Therapy Area, 2012 to YTD 2018 8
Polyphor AG, Medical Devices Deals, 2012 to YTD 2018 9
Polyphor AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Polyphor Enters into Licensing Agreement with PARI Pharma 11
Polyphor Enters into Research Agreement with Taisho Pharma 12
Santhera Pharma Enters into Licensing Agreement with Polyphor 13
Polyphor Extends Licensing Agreement with Boehringer Ingelheim 14
Gilead Sciences Enters Into Licensing Agreement With Polyphor 15
Polyphor Raises USD167.4 Million in IPO of Shares 16
Polyphor Raises USD10 Million in Private Financing 17
Polyphor AG, Key Competitors 18
Polyphor AG, Key Employees 19

List Of Figures


Polyphor AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Polyphor AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Polyphor AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Polyphor AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Polyphor AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Polyphor AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Polyphor AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Polyphor AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Polyphor AG, Medical Devices Deals, 2012 to YTD 2018 9

Polyphor AG (POLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Polyphor AG (Polyphor) is a clinical stage biopharmaceutical company that discovers and develops antibiotics and other specialty pharma products for severe or life-threatening diseases. The company offers hematopoietic stem cells

USD 250 View Report

Polyphor Ltd Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Polyphor Ltd Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile, future

USD 200 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available